請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41049完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 郭彥彬(Yen-Ping Kuo),蕭宏昇(Michael Hsiao) | |
| dc.contributor.author | Po-Sheng Huang | en |
| dc.contributor.author | 黃柏盛 | zh_TW |
| dc.date.accessioned | 2021-06-14T17:13:52Z | - |
| dc.date.available | 2018-07-28 | |
| dc.date.copyright | 2008-09-11 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-07-28 | |
| dc.identifier.citation | Adams, J.Y., Johnson, M., Sato, M., Berger, F., Gambhir, S.S., Carey, M., Iruela-Arispe, M.L., and Wu, L. (2002). Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 8, 891-897.
Aiken, C. (1997). Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J Virol 71, 5871-5877. Akkina, R.K., Walton, R.M., Chen, M.L., Li, Q.X., Planelles, V., and Chen, I.S. (1996). High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J Virol 70, 2581-2585. Blot, W.J., McLaughlin, J.K., Winn, D.M., Austin, D.F., Greenberg, R.S., Preston-Martin, S., Bernstein, L., Schoenberg, J.B., Stemhagen, A., and Fraumeni, J.F., Jr. (1988). Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48, 3282-3287. Bortul, R., Tazzari, P.L., Billi, A.M., Tabellini, G., Mantovani, I., Cappellini, A., Grafone, T., Martinelli, G., Conte, R., and Martelli, A.M. (2005). Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. British journal of haematology 129, 677-686. Boyle, P., Macfarlane, G.J., and Scully, C. (1993). Oral cancer: necessity for prevention strategies. Lancet 342, 1129. Chun, K.H., Kosmeder, J.W., 2nd, Sun, S., Pezzuto, J.M., Lotan, R., Hong, W.K., and Lee, H.Y. (2003). Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. Journal of the National Cancer Institute 95, 291-302. Cockrell, A.S., and Kafri, T. (2007). Gene delivery by lentivirus vectors. Mol Biotechnol 36, 184-204. Contag, C.H., Jenkins, D., Contag, P.R., and Negrin, R.S. (2000). Use of reporter genes for optical measurements of neoplastic disease in vivo. Neoplasia 2, 41-52. Contag, P.R. (2002). Whole-animal cellular and molecular imaging to accelerate drug development. Drug Discov Today 7, 555-562. De, A., and Gambhir, S.S. (2005). Noninvasive imaging of protein-protein interactions from live cells and living subjects using bioluminescence resonance energy transfer. FASEB J 19, 2017-2019. Dehari, H., Ito, Y., Nakamura, T., Kobune, M., Sasaki, K., Yonekura, N., Kohama, G., and Hamada, H. (2003). Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer. Cancer Gene Ther 10, 75-85. Dell'Eva, R., Ambrosini, C., Minghelli, S., Noonan, D.M., Albini, A., and Ferrari, N. (2007). The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF-kappaB pathway. Carcinogenesis 28, 404-413. Dubois, R.N., Abramson, S.B., Crofford, L., Gupta, R.A., Simon, L.S., Van De Putte, L.B., and Lipsky, P.E. (1998). Cyclooxygenase in biology and disease. FASEB J 12, 1063-1073. Edinger, M., Cao, Y.A., Hornig, Y.S., Jenkins, D.E., Verneris, M.R., Bachmann, M.H., Negrin, R.S., and Contag, C.H. (2002). Advancing animal models of neoplasia through in vivo bioluminescence imaging. Eur J Cancer 38, 2128-2136. El-Bayoumy, K., Iatropoulos, M., Amin, S., Hoffmann, D., and Wynder, E.L. (1999). Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: the impact of a high-fat diet. Cancer research 59, 1400-1403. El Hilali, N., Rubio, N., Martinez-Villacampa, M., and Blanco, J. (2002). Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases. Lab Invest 82, 1563-1571. Fang, N., and Casida, J.E. (1998). Anticancer action of cube insecticide: correlation for rotenoid constituents between inhibition of NADH:ubiquinone oxidoreductase and induced ornithine decarboxylase activities. Proceedings of the National Academy of Sciences of the United States of America 95, 3380-3384. Folkman, J. (1992). The role of angiogenesis in tumor growth. Semin Cancer Biol 3, 65-71. Folkman, J. (1997). Angiogenesis and angiogenesis inhibition: an overview. EXS 79, 1-8. Gambhir, S.S. (2002). Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2, 683-693. Gerhauser, C., Lee, S.K., Kosmeder, J.W., Moriarty, R.M., Hamel, E., Mehta, R.G., Moon, R.C., and Pezzuto, J.M. (1997). Regulation of ornithine decarboxylase induction by deguelin, a natural product cancer chemopreventive agent. Cancer research 57, 3429-3435. Gomes, C.M., Welling, M., Que, I., Henriquez, N.V., van der Pluijm, G., Romeo, S., Abrunhosa, A.J., Botelho, M.F., Hogendoorn, P.C., Pauwels, E.K., et al. (2007). Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi. Eur J Nucl Med Mol Imaging 34, 1793-1803. Griesenbach, U., Meng, C., Farley, R., Cheng, S.H., Scheule, R.K., Davies, M.H., Wolstenholme-Hogg, P.C., ten Hove, W., van der Hoeven, P., Sinn, P.L., et al. (2008). In vivo imaging of gene transfer to the respiratory tract. Biomaterials 29, 1533-1540. Hadaschik, B.A., Black, P.C., Sea, J.C., Metwalli, A.R., Fazli, L., Dinney, C.P., Gleave, M.E., and So, A.I. (2007). A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging. BJU Int 100, 1377-1384. Hail, N., Jr., and Lotan, R. (2004). Apoptosis induction by the natural product cancer chemopreventive agent deguelin is mediated through the inhibition of mitochondrial bioenergetics. Apoptosis 9, 437-447. Hecht, S.S. (2005). Deguelin as a chemopreventive agent in mouse lung tumorigenesis induced by tobacco smoke carcinogens. Journal of the National Cancer Institute 97, 1634-1635. Hindle, I., Downer, M.C., and Speight, P.M. (1996). The epidemiology of oral cancer. Br J Oral Maxillofac Surg 34, 471-476. Iyer, M., Salazar, F.B., Wu, L., Carey, M., and Gambhir, S.S. (2006). Bioluminescence imaging of systemic tumor targeting using a prostate-specific lentiviral vector. Hum Gene Ther 17, 125-132. Jenkins, D.E., Yu, S.F., Hornig, Y.S., Purchio, T., and Contag, P.R. (2003). In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer. Clin Exp Metastasis 20, 745-756. Kay, M.A., Glorioso, J.C., and Naldini, L. (2001). Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7, 33-40. Ko, Y.C., Chiang, T.A., Chang, S.J., and Hsieh, S.F. (1992). Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med 21, 261-264. Kok, S.H., Hong, C.Y., Lin, S.K., Lee, J.J., Chiang, C.P., and Kuo, M.Y. (2007). Establishment and characterization of a tumorigenic cell line from areca quid and tobacco smoke-associated buccal carcinoma. Oral Oncol 43, 639-647. Kutschka, I., Kofidis, T., Chen, I.Y., von Degenfeld, G., Zwierzchoniewska, M., Hoyt, G., Arai, T., Lebl, D.R., Hendry, S.L., Sheikh, A.Y., et al. (2006). Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation 114, I174-180. La Vecchia, C., Lucchini, F., Negri, E., and Levi, F. (2004). Trends in oral cancer mortality in Europe. Oral Oncol 40, 433-439. Laxman, B., Hall, D.E., Bhojani, M.S., Hamstra, D.A., Chenevert, T.L., Ross, B.D., and Rehemtulla, A. (2002). Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A 99, 16551-16555. Lee, H.Y., Oh, S.H., Woo, J.K., Kim, W.Y., Van Pelt, C.S., Price, R.E., Cody, D., Tran, H., Pezzuto, J.M., Moriarty, R.M., et al. (2005). Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. Journal of the National Cancer Institute 97, 1695-1699. Lee, H.Y., Suh, Y.A., Kosmeder, J.W., Pezzuto, J.M., Hong, W.K., and Kurie, J.M. (2004). Deguelin-induced inhibition of cyclooxygenase-2 expression in human bronchial epithelial cells. Clin Cancer Res 10, 1074-1079. Lewis, P., Hensel, M., and Emerman, M. (1992). Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 11, 3053-3058. Lippman, S.M., and Hong, W.K. (2001). Molecular markers of the risk of oral cancer. N Engl J Med 344, 1323-1326. MacDonald, N.J., and Steeg, P.S. (1993). Molecular basis of tumour metastasis. Cancer Surv 16, 175-199. Macfarlane, G.J., Boyle, P., Evstifeeva, T.V., Robertson, C., and Scully, C. (1994). Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control 5, 259-265. Mao, L., Hong, W.K., and Papadimitrakopoulou, V.A. (2004). Focus on head and neck cancer. Cancer Cell 5, 311-316. Mehta, R.G., and Pezzuto, J.M. (2002). Discovery of cancer preventive agents from natural products: from plants to prevention. Curr Oncol Rep 4, 478-486. Miller, A.D., Miller, D.G., Garcia, J.V., and Lynch, C.M. (1993). Use of retroviral vectors for gene transfer and expression. Methods Enzymol 217, 581-599. Miyoshi, H., Blomer, U., Takahashi, M., Gage, F.H., and Verma, I.M. (1998). Development of a self-inactivating lentivirus vector. J Virol 72, 8150-8157. Mulligan, R.C. (1993). The basic science of gene therapy. Science 260, 926-932. Murillo, G., Kosmeder, J.W., 2nd, Pezzuto, J.M., and Mehta, R.G. (2003). Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice. International journal of cancer 104, 7-11. Nair, A.S., Shishodia, S., Ahn, K.S., Kunnumakkara, A.B., Sethi, G., and Aggarwal, B.B. (2006). Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion. J Immunol 177, 5612-5622. Naldini, L., Blomer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F.H., Verma, I.M., and Trono, D. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267. Negri, E., La Vecchia, C., Franceschi, S., and Tavani, A. (1993). Attributable risk for oral cancer in northern Italy. Cancer Epidemiol Biomarkers Prev 2, 189-193. Oh, S.H., Woo, J.K., Jin, Q., Kang, H.J., Jeong, J.W., Kim, K.W., Hong, W.K., and Lee, H.Y. (2008). Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha. International journal of cancer 122, 5-14. Ohnishi, Y., Lieger, O., Attygalla, M., Iizuka, T., and Kakudo, K. (2008). Effects of epidermal growth factor on the invasion activity of the oral cancer cell lines HSC3 and SAS. Oral Oncol. Okumura, K., Konishi, A., Tanaka, M., Kanazawa, M., Kogawa, K., and Niitsu, Y. (1996). Establishment of high- and low-invasion clones derived for a human tongue squamous-cell carcinoma cell line SAS. J Cancer Res Clin Oncol 122, 243-248. Parkin, D.M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108. Parkin, D.M., Laara, E., and Muir, C.S. (1988). Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41, 184-197. Pastine, S.J., and Sames, D. (2003). Concise synthesis of the chemopreventitive agent (+/-)-deguelin via a key 6-endo hydroarylation. Organic letters 5, 4053-4055. Prince, M.E., and Ailles, L.E. (2008). Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 26, 2871-2875. Quinonez, R., and Sutton, R.E. (2002). Lentiviral vectors for gene delivery into cells. DNA Cell Biol 21, 937-951. Rehemtulla, A., Stegman, L.D., Cardozo, S.J., Gupta, S., Hall, D.E., Contag, C.H., and Ross, B.D. (2000). Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia 2, 491-495. Resor, L., Bowen, T.J., and Wynshaw-Boris, A. (2001). Unraveling human cancer in the mouse: recent refinements to modeling and analysis. Hum Mol Genet 10, 669-675. Sailasree, R., Abhilash, A., Sathyan, K.M., Nalinakumari, K.R., Thomas, S., and Kannan, S. (2008). Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma. Cancer Epidemiol Biomarkers Prev 17, 414-420. Saranath, D. (2000). Contemporary Issues in Oral Cancer. Scatena, C.D., Hepner, M.A., Oei, Y.A., Dusich, J.M., Yu, S.F., Purchio, T., Contag, P.R., and Jenkins, D.E. (2004). Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer. Prostate 59, 292-303. Shindoh, M., Higashino, F., Kaya, M., Yasuda, M., Funaoka, K., Hanzawa, M., Hida, K., Kohgo, T., Amemiya, A., Yoshida, K., et al. (1996). Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines. Am J Pathol 148, 693-700. Sinn, P.L., Burnight, E.R., Hickey, M.A., Blissard, G.W., and McCray, P.B., Jr. (2005). Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol 79, 12818-12827. Szpak, C.A., Stone, M.J., and Frenkel, E.P. (1977). Some observations concerning the demographic and geographic incidence of carcinoma of the lip and buccal cavity. Cancer 40, 343-348. Udeani, G.O., Gerhauser, C., Thomas, C.F., Moon, R.C., Kosmeder, J.W., Kinghorn, A.D., Moriarty, R.M., and Pezzuto, J.M. (1997). Cancer chemopreventive activity mediated by deguelin, a naturally occurring rotenoid. Cancer research 57, 3424-3428. Udeani, G.O., Zhao, G.M., Shin, Y.G., Kosmeder, J.W., 2nd, Beecher, C.W., Kinghorn, A.D., Moriarty, R.M., Moon, R.C., and Pezzuto, J.M. (2001). Pharmacokinetics of deguelin, a cancer chemopreventive agent in rats. Cancer Chemother Pharmacol 47, 263-268. Vigna, E., and Naldini, L. (2000). Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2, 308-316. Vokes, E.E., Weichselbaum, R.R., Lippman, S.M., and Hong, W.K. (1993). Head and neck cancer. N Engl J Med 328, 184-194. Vooijs, M., Jonkers, J., Lyons, S., and Berns, A. (2002). Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 62, 1862-1867. Wang, W., Kim, S.H., and El-Deiry, W.S. (2006). Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts. Proc Natl Acad Sci U S A 103, 11003-11008. Weissleder, R. (2002). Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2, 11-18. Welch, D.R., and Rinker-Schaeffer, C.W. (1999). What defines a useful marker of metastasis in human cancer? J Natl Cancer Inst 91, 1351-1353. Wen, C.P., Tsai, S.P., Cheng, T.Y., Chen, C.J., Levy, D.T., Yang, H.J., and Eriksen, M.P. (2005). Uncovering the relation between betel quid chewing and cigarette smoking in Taiwan. Tob Control 14 Suppl 1, i16-22. West, K.A., Castillo, S.S., and Dennis, P.A. (2002). Activation of the PI3K/Akt pathway and chemotherapeutic resistance. Drug Resist Updat 5, 234-248. Wilber, A., Frandsen, J.L., Wangensteen, K.J., Ekker, S.C., Wang, X., and McIvor, R.S. (2005). Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging. Hum Gene Ther 16, 1325-1332. Wiles, S., Pickard, K.M., Peng, K., MacDonald, T.T., and Frankel, G. (2006). In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect Immun 74, 5391-5396. Yoshida, B.A., Sokoloff, M.M., Welch, D.R., and Rinker-Schaeffer, C.W. (2000). Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst 92, 1717-1730. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/41049 | - |
| dc.description.abstract | 根據2006年統計，口腔癌已成為台灣所有癌症死亡原因的第六名。而以男性癌症十大死亡原因來看，口腔癌則排名第五名。發病後除了會使患者的外表看起來很不健全之外，在最近的二十幾年內其五年小於50%的存活率並沒有明顯提升。鱗狀上皮細胞癌在口腔以及頜面區為最常發生的口腔癌，由於它的易轉移以及易入侵的能力而常導致較差的預後結果。在我們的研究中，我們首先決定不同的慢病毒劑量對七株口腔癌細胞株以及OMF的感染效率。藉由得到的感染效率結果，我們利用帶有綠色螢光蛋白以及冷光酶的慢病毒以20 MOI來感染Ca922以及SAS來建立能持續表現綠色螢光蛋白以及冷光酶的Ca922-GL和SAS-GL的細胞株。藉由這兩株細胞株，我們在小鼠建立起 Ca922以及SAS的原位腫瘤模式。在生物冷光影像觀察的結果中，我們發現Ca922是較不會轉移的細胞株，而SAS則是較會轉移的細胞株且腫瘤的生長速度也比較快。在SAS的原位腫瘤動物模式中，我們發現會轉移到唾腺的區域。然而，在Ca922的原位腫瘤動物模式中，則不會發現在此區域有轉移的腫瘤。
Deguelin是一種天然萃取的化合物，為一種AKT抑制劑。在細胞存活測試的實驗中，我們發現Ca922、Cal27以及SAS是對deguelin較敏感的口腔癌細胞株。之後，我們在腫瘤生長較快的SAS原位腫瘤模式以0.8 mg/kg和4 mg/kg 的deguelin劑量來餵食老鼠，觀察是否能抑制腫瘤的大小。在以4 mg/kg餵食的實驗組，其腫瘤大小相較於對照組有顯著的變小。而在劑量較低的0.8 mg/kg餵食的實驗組，其腫瘤大小也有明顯的抑制。由我們的研究結果顯示，deguelin可以有效的抑制口腔癌腫瘤大小的生長。未來在治療口腔鱗狀上皮細胞癌時，deguelin或許可被視為一種新的策略。 | zh_TW |
| dc.description.abstract | In Taiwan, oral cancer is the sixth leading cause of cancer-related death in year 2006, and it is the fifth leading cause of cancer-related deaths in male population on this island. The disease causes great morbidity, and the five-year survival rate of less than 50 % has not improved in more than two decades. Squamous cell carcinoma (SCC) is the most frequently a occurred cancer in the oral and maxillofacial regions, and its metastatic and invasive abilities tendencies made it difficult in prognostic control.
In our study, we determined infection efficiencies in seven oral cancer cell lines and oral mucosa fibroblast (OMF) with different lentivirus dosage. The results suggested that using lentivirus for gene delivery is a promising method. We used 20 MOI GL-lentivirus to infect Ca922 and SAS cell lines to establish stable cell lines with GL expression. The Ca922-GL and SAS-GL orthotopic tumor models were established by these two stable cell lines. Based on bioluminescent imaging observation, SAS was highly invasive cell line, while Ca922-GL was not an invasive cell line in vivo. In SAS-GL orthotopic model, a metastatic tumor was observed on salivary gland. However, in Ca922-GL orthotopic model, no metastatic tumor was found in mice at all. Deguelin is a natural product and an AKT inhibitor. In cell viability assay, Ca922, Cal27, and SAS were sensitive to deguelin. To determine the inhibition efficacy of deguelin treatment on tumor growth, we used SAS-GL orthotopic tumor model with 0.8 mg/kg and 4 mg/kg deguelin treatment. In 4 mg/kg deguelin treatment, the tumor volume in SAS-GL orthotopic tumor model was significantly smaller than the control group. In addition, treatment with 0.8 mg/kg deguelin in SAS-GL orthotopic tumor model also resulted in a smaller tumor. Overall, our results indicated that the tumor growth of oral cancer could be inhibited by deguelin treatment, and this novel strategy may provide an additional treatment for OSCC | en |
| dc.description.provenance | Made available in DSpace on 2021-06-14T17:13:52Z (GMT). No. of bitstreams: 1 ntu-97-R95450016-1.pdf: 4966686 bytes, checksum: 963af5a846e982429907c6dbcf5268a5 (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | Contents
Abbreviations 2 中文摘要 3 Abstract 4 Chapter 1 General Introduction 6 1.1 Background and significance 7 1.2 Specific aims 18 Chapter 2 Materials and Methods 19 Chapter 3 Results 35 3.1 Infection efficiency test in oral cancer cell lines 36 3.2 Establishment of GL stable cell lines 38 3.3 Establishment of oral cancer orthotopic tumor model 39 3.4 Efficacy of deguelin on SAS-GL induced Oral tumorigenesis 41 Chapter 4 Discussion 72 Chapter 5 Future Perspectives 81 References 90 Appendix 103 | |
| dc.language.iso | en | |
| dc.title | 原位口腔癌動物模式之建立與魚藤素抑制口腔癌轉移之探討 | zh_TW |
| dc.title | Establishment of orthotopic oral cancer models and evaluation of the inhibition effects of deguelin on tumor metastasis | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 洪致遠 | |
| dc.subject.keyword | 魚藤素,生物冷光成像,口腔鱗狀細胞癌, | zh_TW |
| dc.subject.keyword | deguelin,Bioluminescent imaging,Oral squamous cell carcinoma, | en |
| dc.relation.page | 119 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2008-07-28 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
| 顯示於系所單位： | 口腔生物科學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf 目前未授權公開取用 | 4.85 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。